Is the duration of dual antiplatelet therapy (DAPT) excessive in post-angioplasty in chronic coronary syndrome? Data from the France-PCI registry (2014–2019)

BACKGROUND: while the duration of dual antiplatelet therapy (DAPT) following coronary angioplasty for chronic coronary syndrome (CCS) recommended by the European Society of Cardiology has decreased over the last decade, little is known about the adherence to those guidelines in clinical practice in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mezier, A., Motreff, P., Clerc, J. M., Bar, O., Deballon, R., Demicheli, T., Dechery, T., Souteyrand, G., Py, A., Lhoest, N., Lhermusier, T., Honton, B., Gommeaux, A., Jeanneteau, J., Deharo, P., Benamer, H., Cayla, G., Koning, R., Pereira, B., Collet, J. P., Rangé, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080068/
https://www.ncbi.nlm.nih.gov/pubmed/37034332
http://dx.doi.org/10.3389/fcvm.2023.1106503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080068/
https://www.ncbi.nlm.nih.gov/pubmed/37034332
http://dx.doi.org/10.3389/fcvm.2023.1106503

Ejemplares similares